Kebede H Begna (Kebede Begna, K H Begna)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 83

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Top Venues

American journal of hematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Naseema Gangat, Amritpal Singh, Rimal Ilyas, Giuseppe Gaetano Loscocco, Michelle A Elliott, Kebede H Begna, Animesh D Pardanani, Ayalew Tefferi
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies. American journal of hematology (2024)
Ayalew Tefferi, Animesh Pardanani, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Rhett P Ketterling, Kaaren K Reichard, Naseema Gangat
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant. Blood cancer journal 14 (1) (2024)
Ayalew Tefferi, Animesh Pardanani, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Rhett P Ketterling, Kaaren K Reichard, Naseema Gangat
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant. Blood cancer journal 14 (1) (2024)
Naseema Gangat, Omer S Karrar, Aref A Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 14 (1) (2024)
Naseema Gangat, Omer S Karrar, Aref A Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 14 (1) (2024)
Naseema Gangat, Omer S Karrar, Aref A Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 14 (1) (2024)
Ayalew Tefferi, Animesh Pardanani, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Rhett P Ketterling, Kaaren K Reichard, Naseema Gangat
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant. Blood cancer journal 14 (1) (2024)
Hagop M Kantarjian, Kebede H Begna, Elias J Jabbour, Shilpa Paul, Mary Alma Welch, Ayalew Tefferi
Optimal frontline therapy of chronic myeloid leukemia today, and related musings. American journal of hematology (2024)
Naseema Gangat, Omer S Karrar, Aref A Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 14 (1) (2024)
Ayalew Tefferi, Animesh D Pardanani, Aref A Al-Kali, Hassan Alkhateeb, McCullough Kristen, Mirinal S Patnaik, William J Hogan, Kebede H Begna, Michelle A Elliott, Nandita Khera, Jeanne M Palmer, Naseema Gangat, Katalin Kelemen, Attilio Orazi, Dong Chen, Kaaren K Reichard
Mast cell cytomorphology and treatment outcome in mast cell leukemia. American journal of hematology (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Fernanda Gutierrez-Rodrigues, Yael N Kusne, Jenna Fernandez, Terra L Lasho, Ruba N Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy M Finke, Matthew J Koster, Abhishek A Mangaonkar, Kenneth J Warrington, Kebede H Begna, Zhuoer Xie, Amanda K Ombrello, David S Viswanatha, Marcela A Ferrada, Lorena Wilson, Ronald S Go, Taxiarchis V Kourelis, Kaaren K Reichard, Horatiu Olteanu, Ivana Darden, Dalton Hironaka, Lemlem Alemu, Sachiko Kajigaya, Rodrigo do Tocantins Calado, Emma M Groarke, Sofia Rosenzweig, Daniel L Kastner, Katherine R Calvo, Colin O Wu, Peter C Grayson, Neal S Young, David B Beck, Bhavisha A Patel, Mirinal S Patnaik
Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood (2023)
Naseema Gangat, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Animesh Pardanani, Ayalew Tefferi
Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor. Blood cancer journal 13 (1) (2023)
Ayalew Tefferi, Maymona Abdelmagid, Aref A Al-Kali, Mirinal S Patnaik, William J Hogan, Kebede H Begna, Naseema Gangat, Attilio Orazi, Dong Chen, Kaaren K Reichard, Animesh D Pardanani
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): a Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Aref A Al-Kali, Raoul Tibes, Pamela Atherton, Jeanne Palmer, Hassan B Alkhateeb, Mirinal S Patnaik, Kebede H Begna, Naseema Gangat, Shahrukh Hashmi, Rong He, Mark R Litzow
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression. American journal of hematology 98 (3) (2023)
Naseema Gangat, Omer S Karrar, Moazah Iftikhar, McCullough Kristen, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Naseema Gangat, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Animesh Pardanani, Ayalew Tefferi
Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor. Blood cancer journal 13 (1) (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Aref A Al-Kali, Raoul Tibes, Pamela Atherton, Jeanne Palmer, Hassan B Alkhateeb, Mirinal S Patnaik, Kebede H Begna, Naseema Gangat, Shahrukh Hashmi, Rong He, Mark R Litzow
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression. American journal of hematology (2023)
Fernanda Gutierrez-Rodrigues, Yael N Kusne, Jenna Fernandez, Terra L Lasho, Ruba N Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy M Finke, Matthew J Koster, Abhishek A Mangaonkar, Kenneth J Warrington, Kebede H Begna, Zhuoer Xie, Amanda K Ombrello, David S Viswanatha, Marcela A Ferrada, Lorena Wilson, Ronald S Go, Taxiarchis V Kourelis, Kaaren K Reichard, Horatiu Olteanu, Ivana Darden, Dalton Hironaka, Lemlem Alemu, Sachiko Kajigaya, Rodrigo do Tocantins Calado, Emma M Groarke, Sofia Rosenzweig, Daniel L Kastner, Katherine R Calvo, Colin O Wu, Peter C Grayson, Neal S Young, David B Beck, Bhavisha A Patel, Mirinal S Patnaik
Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood (2023)
Aref A Al-Kali, Raoul Tibes, Pamela Atherton, Jeanne Palmer, Hassan B Alkhateeb, Mirinal S Patnaik, Kebede H Begna, Naseema Gangat, Shahrukh Hashmi, Rong He, Mark R Litzow
A Phase II Study of Combination Daunorubicin, Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia with KIT Expression. American journal of hematology (2023)
Fernanda Gutierrez-Rodrigues, Yael N Kusne, Jenna Fernandez, Terra L Lasho, Ruba N Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy M Finke, Matthew J Koster, Abhishek A Mangaonkar, Kenneth J Warrington, Kebede H Begna, Zhuoer Xie, Amanda K Ombrello, David S Viswanatha, Marcela A Ferrada, Lorena Wilson, Ronald S Go, Taxiarchis V Kourelis, Kaaren K Reichard, Horatiu Olteanu, Ivana Darden, Dalton Hironaka, Lemlem Alemu, Sachiko Kajigaya, Rodrigo do Tocantins Calado, Emma M Groarke, Sofia Rosenzweig, Daniel L Kastner, Katherine R Calvo, Colin O Wu, Peter C Grayson, Neal S Young, David B Beck, Bhavisha A Patel, Mirinal S Patnaik
Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood (2023)
Naseema Gangat, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Animesh Pardanani, Ayalew Tefferi
Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor. Blood cancer journal 13 (1) (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Fernanda Gutierrez-Rodrigues, Yael N Kusne, Jenna Fernandez, Terra L Lasho, Ruba N Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy M Finke, Matthew J Koster, Abhishek A Mangaonkar, Kenneth J Warrington, Kebede H Begna, Zhuoer Xie, Amanda K Ombrello, David S Viswanatha, Marcela A Ferrada, Lorena Wilson, Ronald S Go, Taxiarchis V Kourelis, Kaaren K Reichard, Horatiu Olteanu, Ivana Darden, Dalton Hironaka, Lemlem Alemu, Sachiko Kajigaya, Rodrigo do Tocantins Calado, Emma M Groarke, Sofia Rosenzweig, Daniel L Kastner, Katherine R Calvo, Colin O Wu, Peter C Grayson, Neal S Young, David B Beck, Bhavisha A Patel, Mirinal S Patnaik
Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Aref A Al-Kali, Raoul Tibes, Pamela Atherton, Jeanne Palmer, Hassan B Alkhateeb, Mirinal S Patnaik, Kebede H Begna, Naseema Gangat, Shahrukh Hashmi, Rong He, Mark R Litzow
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression. American journal of hematology 98 (3) (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Naseema Gangat, Mostafa Abdallah, Natasha Szuber, Antoine N Saliba, Hassan Alkhateeb, Aref A Al-Kali, Kebede H Begna, Animesh D Pardanani, Ayalew Tefferi
Sodium-glucose co-transporter-2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases. American journal of hematology (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Animesh D Pardanani, Ayalew Tefferi, Aref A Al-Kali, Mirinal S Patnaik, William J Hogan, Kebede H Begna, Michelle A Elliott, Nandita Khera, Jeanne M Palmer, Naseema Gangat, Attilio Orazi, Katalin Kelemen, Kaaren K Reichard, Dong Chen
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome. American journal of hematology (2023)
Naseema Gangat, Andrew T Kuykendall, Najla H Al Ali, Swati Goel, Maymona Abdelmagid, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek A Mangaonkar, Mark R Litzow, William Joseph Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Rami S Komrokji, Ayalew Tefferi
Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival. Blood advances (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Maymona G Abdelmagid, Aref A Al-Kali, Mark R Litzow, Kebede H Begna, William Joseph Hogan, Mirinal S Patnaik, Shahrukh K. Hashmi, Michelle A Elliott, Hassan B Alkhateeb, Omer S Karrar, Farah Fleti, Mohammed H Elnayir, Candido E Rivera, Hemant S Murthy, James M Foran, Mohamed A Kharfan-Dabaja, Talha Badar, David S Viswanatha, Kaaren K Reichard, Naseema Gangat, Ayalew Tefferi
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events. Blood cancer journal 13 (1) (2023)
Aref A Al-Kali, Raoul Tibes, Pamela Atherton, Jeanne Palmer, Hassan B Alkhateeb, Mirinal S Patnaik, Kebede H Begna, Naseema Gangat, Shahrukh Hashmi, Rong He, Mark R Litzow
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression. American journal of hematology 98 (3) (2023)
Naseema Gangat, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Animesh Pardanani, Ayalew Tefferi
Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor. Blood cancer journal 13 (1) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Ellin Berman, Neil P Shah, Michael W Deininger, Jessica K Altman, Maria Amaya, Kebede H Begna, Ravi Bhatia, Onyee Chan, Robert H Collins, Peter Curtin, Daniel J DeAngelo, Michael W Drazer, Lori Maness, Leland L Metheny, Sanjay Mohan, Joseph Moore, Vivian Oehler, Keith W Pratz, Iskra Pusic, Michal Rose, William Shomali, B Douglas Smith, Michael Styler, Kendra Sweet, Moshe Talpaz, Tiffany Tanaka, Srinivas Tantravahi, Steven Tsai, Jennifer Vaughn, Jeanna Welborn, David Yang, Michael Mauro, Jorge E Cortes, Jerald Radich, Brian J Druker
CML and the WHO: Why? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Aref A Al-Kali, Raoul Tibes, Pamela Atherton, Jeanne Palmer, Hassan B Alkhateeb, Mirinal S Patnaik, Kebede H Begna, Naseema Gangat, Shahrukh Hashmi, Rong He, Mark R Litzow
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression. American journal of hematology 98 (3) (2023)
Naseema Gangat, Kebede H Begna, Aref A Al-Kali, William Joseph Hogan, Mark R Litzow, Animesh Pardanani, Ayalew Tefferi
Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor. Blood cancer journal 13 (1) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Naseema Gangat, Kebede H Begna, Aref A Al-Kali, William Hogan, Mark R Litzow, Animesh D Pardanani, Ayalew Tefferi
Predictors of anemia response to momelotinib therapy in myelofibrosis and impact on survival. American journal of hematology (2022)
Naseema Gangat, Natasha Szuber, Yamna Jadoon, Faiqa Farrukh, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Curtis A Hanson, Animesh D Pardanani, Valerio De Stefano, Tiziano Barbui, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events. Blood advances 6 (13) (2022)
Kebede H Begna, X Xu, Naseema Gangat, Hassan B Alkhateeb, Mirinal S Patnaik, Aref A Al-Kali, M A Elliott, William Joseph Hogan, Mark R Litzow, C C Hook, A P Wolanskyj-Spinner, Abhishek A Mangaonkar, Rong He, A Pardanani, Mithun Vinod Shah, R P Ketterling, Ayalew Tefferi
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3". Blood cancer journal 12 (4) (2022)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
Ayalew Tefferi, Animesh D Pardanani, Kebede H Begna, Aref A Al-Kali, William J Hogan, Mark R Litzow, Curtis A Hanson, Rhett P Ketterling, Naseema Gangat
Momelotinib for myelofibrosis: 12-year survival data and retrospective comparison to ruxolitinib. American journal of hematology 97 (12) (2022)
Abhishek A Mangaonkar, Faiqa Farrukh, Kaaren K Reichard, Rhett P Ketterling, Naseema Gangat, Aref Al-Kali, Kebede H Begna, Animesh D Pardanani, Mirinal S Patnaik, Ayalew Tefferi
Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS-RS) but not in MDS/MPN-RS-T. American journal of hematology 97 (3) (2022)
Ayalew Tefferi, Kebede H Begna, McCullough Kristen
Tyrosine kinase inhibitors dosing for chronic phase chronic myeloid leukemia: The case for starting low with dasatinib (50 mg/day) and ponatinib (15 mg/day). American journal of hematology 97 (11) (2022)
Isla M Johnson, Evandro D Bezerra, Faiqa Farrukh, McCullough Kristen, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Mark R Litzow, William J Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Ayalew Tefferi, Naseema Gangat
Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents. Blood advances 6 (17) (2022)
Naseema Gangat, McCullough Kristen, Isla Johnson, Aref Al-Kali, Kebede H Begna, Mirinal S Patnaik, Mark R Litzow, William Hogan, Mithun Vinod Shah, Hassan Alkhateeb, Abhishek A Mangaonkar, James M Foran, Talha Badar, Jeanne M Palmer, Lisa Sproat, Cecilia Y Arana Yi, Animesh D Pardanani, Ayalew Tefferi
Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts. American journal of hematology 97 (6) (2022)
Rong He, Jonathan Chiou, Allison Chiou, Dong Chen, Constance P Chen, Caroline Spethman, Kurt R Bessonen, Jennifer L Oliveira, Phuong L Nguyen, Kaaren K Reichard, James D Hoyer, Simon D Althoff, Dana J Roh, Mechelle A Miller, Ji Yuan, Horatiu Olteanu, Kebede H Begna, Ayalew Tefferi, Hassan B Alkhateeb, Mirinal S Patnaik, Mark R Litzow, Aref A Al-Kali, David S Viswanatha
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients. Blood cancer journal 12 (1) (2022)
Bahga Katamesh, Ahmad Nanaa, Rong He, David S Viswanatha, Phuong Nguyen, Patricia T Greipp, Kurt Bessonen, Naseema Gangat, Kebede H Begna, Abhishek A Mangaonkar, Mirinal S Patnaik, William J Hogan, Ayalew Tefferi, Mark R Litzow, Mithun Vinod Shah, Cecilia Arana-Yi, James M Foran, Talha Badar, Hassan B Alkhateeb, Aref A Al-Kali
Clinical and Prognostic Impact of STAG2 Mutations in Myeloid Neoplasms: The Mayo Clinic Experience. Blood advances (2022)
Naseema Gangat, Deandra Chetram, McCullough Kristen, Aref A Al-Kali, Kebede H Begna, William Hogan, Mark R Litzow, James Foran, Talha Badar, Jeanne Palmer, Mirinal S Patnaik, Animesh D Pardanani, Ayalew Tefferi
Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts. American journal of hematology 97 (12) (2022)
Amritpal Singh, Aref A Al-Kali, James M Foran, Michelle A Elliott, Kebede H Begna, Talha Badar, Nandita Khera, Farah Fleti, Maymona Abdelmagid, Kareen K Reichard, Rhett P Ketterling, Animesh D Pardanani, Naseema Gangat, Ayalew Tefferi
Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting. American journal of hematology 97 (10) (2022)
Faiqa Farrukh, Naseema Gangat, Mithun Vinod Shah, Mark R Litzow, Michelle A Elliott, Kebede H Begna, Christopher C Hook, Ayalew Tefferi, Animesh D Pardanani
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience. American journal of hematology 97 (4) (2022)
Ayalew Tefferi, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Vinod Shah, Mirinal S Patnaik, Michelle A Elliott, William J Hogan, Mark R Litzow, Christopher C Hook, Abhishek A Mangaonkar, David Viswanatha, Dong Chen, Animesh D Pardanani, Rhett P Ketterling, Courtney D D DiNardo, Tapan Mahendra Kadia, Farhad Ravandi, Koji Sasaki, Kebede H Begna
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy. American journal of hematology 97 (9) (2022)
Naseema Gangat, Amritpal Singh, Natasha Szuber, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Curtis A Hanson, Animesh D Pardanani, Valerio De Stefano, Tiziano Barbui, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival. Journal of thrombosis and haemostasis : JTH 20 (10) (2022)
Faiqa Farrukh, Deandra Chetram, Aref Al-Kali, James Foran, Mirinal S Patnaik, Talha Badar, Kebede H Begna, Christopher Hook, William Hogan, McCullough Kristen, Abhishek A Mangaonkar, Rong He, Naseema Gangat, Ayalew Tefferi
Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts. American journal of hematology 97 (6) (2022)
Amritpal Singh, Aref Al-Kali, Kebede H Begna, Mark R Litzow, Jeremy T Larsen, Taimur Sher, Maymona G Abdelmagid, Faiqa Farrukh, Kaaren K Reichard, Naseema Gangat, Animesh D Pardanani, Ayalew Tefferi
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases. American journal of hematology 97 (5) (2022)
Mithun Vinod Shah, Rakchha Chhetri, Ruchita Dholakia, Chung Hoow Kok, Naseema Gangat, Hassan B Alkhateeb, Aref Al-Kali, Mirinal S Patnaik, Anmol Baranwal, Patricia T Greipp, Rong He, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Devendra K Hiwase
Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms. American journal of hematology 97 (8) (2022)
Kebede H Begna, Naseema Gangat, Aref Al-Kali, Mark R Litzow, William J Hogan, Mirinal S Patnaik, Animesh D Pardanani, C Christopher Hook, Alexandra P Wolanskyj, Michelle A Elliott, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy. American journal of hematology 96 (4) (2021)
Hagop M Kantarjian, Kebede H Begna, Jessica K Altman, Stuart L Goldberg, Mikkael A Sekeres, Stephen A Strickland, Martha L Arellano, David F Claxton, Maria R Baer, Marc Gautier, Ellin Berman, Karen Seiter, Scott R Solomon, Gary J Schiller, Selina M Luger, Aleksandra Butrym, Gianluca Gaidano, Xavier G Thomas, Pau Montesinos, David A Rizzieri, Donald P Quick, Parameswaran Venugopal, Rakesh Gaur, Lori J Maness, Tapan Mahendra Kadia, Farhad Ravandi, Marc E Buyse, Judy H Chiao
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer 127 (23) (2021)
Qiuju Liu, Brittny Major, Jennifer Le-Rademacher, Aref A Al-Kali, Hassan Alkhateeb, Kebede H Begna, Michelle A Elliott, Naseema Gangat, William J Hogan, C Christopher Hook, Scott H Kaufmann, Animesh Pardanani, Mrinal S Patnaik, Ayalew Tefferi, Alexandra P Wolanskyj-Spinner, Mark R Litzow, Mark R Litzow
The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia - A Single Center Retrospective Study. Blood and lymphatic cancer : targets and therapy 11 (2021)
Kebede H Begna, Walid Ali, Naseema Gangat, Michelle A Elliott, Aref A Al-Kali, Mark R Litzow, C Christopher Hook, Alexandra P Wolanskyj-Spinner, William Joseph Hogan, Mirinal S Patnaik, Animesh Pardanani, Darci L Zblewski, Dong Chen, Rong He, David Viswanatha, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
Mayo Clinic experience with 1123 adults with acute myeloid leukemia. Blood cancer journal 11 (3) (2021)
Koiji Sasaki, Tapan Mahendra Kadia, Kebede H Begna, Courtney D D DiNardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Guillermo Montalban Bravo, Lucia Masarova, Sherry Pierce, Marina Y Konopleva, Farhad Ravandi, Ayalew Tefferi, Hagop Kantarjian
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. American journal of hematology (2021)
Naseema Gangat, Paola Guglielmelli, Natasha Szuber, Kebede H Begna, Mirinal S Patnaik, Mark R Litzow, Aref Al-Kali, James M Foran, Jeanne M Palmer, Hassan Alkhateeb, Michelle A Elliott, Curtis A Hanson, Animesh D Pardanani, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 96 (7) (2021)
Erika Morsia, McCullough Kristen, Maansi Joshi, Joselle Madonna Cook, Hassan B Alkhateeb, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, William Hogan, Mark R Litzow, Mithun Shah, Animesh Pardanani, Mirinal S Patnaik, Ayalew Tefferi, Naseema Gangat
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients. American journal of hematology 95 (12) (2020)
Gordon J Ruan, Caleb J Smith, Courtney Day, William S Harmsen, Darci L Zblewski, Hassan Alkhateeb, Kebede H Begna, Aref Al-Kali, Mark R Litzow, William Hogan, Naseema Gangat, Mirinal S Patnaik, Animesh Pardanani, Ayalew Tefferi, Ronald S Go, Mithun Vinod Shah
A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United States. American journal of hematology (2020)
Vu H Duong, Kebede H Begna, Sarah Kashanian, Kendra L Sweet, Eunice S Wang, Ryan Caddell, Danielle A Shafer, Zeba N Singh, Maria R Baer, Aref A Al-Kali
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study. Annals of hematology 99 (9) (2020)
Theodora Anagnostou, Ryan A Knudson, Kathryn E Pearce, Reid G Meyer, Beth A Pitel, Jess F Peterson, Linda B Baughn, Kaaren K Reichard, Rhett P Ketterling, Sara M Kloft-Nelson, Darlene L Knutson, Shakila P Khan, Naseema Gangat, Mark R Litzow, William J Hogan, Alexandra Wolanskyj, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Animesh Pardanani, James Foran, Mithun Shah, Ayalew Tefferi, Hassan Alkhateeb, Kevin Halling, Vilmarie Rodriguez, Patricia T Greipp, Mirinal S Patnaik
Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia. American journal of hematology 95 (3) (2020)
Omar Alkharabsheh, Salwa S Saadah, Mirinal S Patnaik, Hassan Alkhateeb, Naseema Gangat, Kebede H Begna, William J Hogan, Patricia T Greipp, Rong He, Phuong L Nguyen, Mark R Litzow, Aref A Al-Kali
Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes. American journal of hematology 93 (12) (2018)
Ayalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, Kebede H Begna, Mirinal S Patnaik, Michelle A Elliott, C Christopher Hook, Alexandra P Wolanskyj, Curtis A Hanson, Rhett P Ketterling, Animesh Pardanani, Naseema Gangat
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide. American journal of hematology 94 (1) (2018)
Kebede H Begna, Walid Ali, Naseema Gangat, Michelle A Elliott, Aref Al-Kali, Mark R Litzow, C Christopher Hook, Alexandra P Wolanskyj, William J Hogan, Mirinal S Patnaik, Animesh Pardanani, Darci L Zblewski, Dong Chen, Rong He, David Viswanatha, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status. American journal of hematology 93 (12) (2018)
John Ogden, Jennifer Yui, Walid Ali, Mythri Mudireddy, Aref Al-Kali, Mirinal S Patnaik, Naseema Gangat, Michelle A Elliott, William Hogan, Christopher Hook, Alexandra Wolanskyj-Spinner, Animesh Pardanani, Hector Villarraga, Mark Litzow, Ayalew Tefferi, Kebede H Begna
Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia. American journal of hematology 93 (6) (2018)
Kebede H Begna, Aref Al-Kali, Michelle Elliott, James Foran, Naseema Gangat, William Hogan, Christopher Hook, Jose Leis, Mark Litzow, Ruben Mesa, Jeanne Palmer, Animesh Pardanani, Mirinal S Patnaik, Candido Rivera, Lisa Sproat, Raoul Tibes, Alexandra Wolanskyj-Spinner, Ayalew Tefferi
Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey. American journal of hematology 92 (11) (2017)